Most people with atypical Alzheimer's may be ineligible for new therapies

2 months ago 7
Many radical with little communal forms of Alzheimer's illness whitethorn not suffice for newer anti-amyloid treatments designed to dilatory the disease, according to a survey published Aug. 5, 2026, successful Neurology.
Read Entire Article